Sign in
4

Changes in Ownership

Keros Therapeutics, Inc. Filed Acc 0001178913-20-001105

10% owner bought 120,000 shares at $16.00 ($1,920,000)

  • 10% owner acquired 1,893,102 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Arkin Bio Ventures Limited Partnership · 10% owner

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2020-04-13 Conversion : show line 1 in the form +1,382,295 1,382,295 D
2020-04-13 Conversion : show line 2 in the form +343,270 1,725,565 D
2020-04-13 Conversion : show line 3 in the form +167,537 1,893,102 D
2020-04-13 Purchase : show line 4 in the form +120,000 $16.00 $1,920,000 2,013,102 D
Open-market purchases · 120,000 sh · avg $16.00 · $1,920,000

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2020-04-13 Conversion : show line 5 in the form Series A Preferred Stock −1,382,295 0 D
2020-04-13 Conversion : show line 6 in the form Series B-1 Preferred Stock −343,270 0 D
2020-04-13 Conversion : show line 7 in the form Series C Preferred Stock −167,537 0 D
Loading xslF345X03/zk2024260.xml…